Congress Sends Hemp Deadline Extension to the President
The Congress hemp extension would postpone most federal hemp-definition changes until December 11, 2026, if the president signs H.R. 6500. Specified synthetic-cannabinoid provisions would remain on the earlier schedule.
Cannabis Use Disorder Is Rising Among US Adults
Cannabis use disorder increased among US adult males and females from 2021 through 2024. The national survey also found growth in moderate-to-severe disorder across several age groups. The findings support routine screening but do not identify a cause or…
Michigan Recalls Infused Drinks Over THC Potency Concerns
Michigan cannabis beverage recall: Michigan is recalling certain 200 mg marijuana-infused drinks after testing raised THC potency concerns. The company is also investigating variability and homogeneity, and the products have an inaccurate serving-count…
Texas THC Ban Remains as Federal Judge Denies Emergency Pause
The Texas THC ban remains in place after a federal judge denied emergency relief. The broader hemp lawsuit and a preliminary-injunction request are still pending. CED explains what changed, what remains uncertain, and why legal availability does not…
UK Medical Cannabis Use: What a New National Survey Found
A new UK national survey examined uk medical cannabis prescriptions and their link to high-risk use. The study found prescribed users more frequently used processed products and screened positive for high-risk use. These findings highlight the need for…
Blog: The Medical AI Safety Checklist Clinicians Need
A medical AI safety checklist helps clinicians decide whether an algorithm fits the task, patient, evidence, and consequences. This guide presents seven checks for population mismatch, missing inputs, hidden uncertainty, automation bias, and performance…
Blog: Can AI-Clinician Collaboration Improve Medical Care?
AI-clinician collaboration can improve medical care when machines extend pattern recognition and clinicians preserve context, verification, and accountability. Evidence suggests that combined performance can improve in defined tasks, but poor advice,…
Texas Hemp Ban Compliance in 2026: Implications for Patients and Clinicians
The 2026 Texas hemp ban compliance debate highlights safety and access concerns for patients using hemp-derived THC products. Lawmakers aim to reduce child exposure and poison-control incidents. Patients and clinicians must understand the evolving…
GLP-1 Receptor Agonist Safety: Counterfeit Drug Risks
Counterfeit GLP-1 medications present serious safety risks including inconsistent dosing and contamination. These unauthorized products can cause adverse events and treatment failures. Clinicians must counsel patients on obtaining GLP-1 drugs from…
Cannabis Edibles and Alcohol Create Synergistic Driving Impairment
A recent study reveals that cannabis edibles and alcohol produce synergistic impairment that exceeds the combined effects of either substance used alone. This finding has significant implications for patient counseling, as clinicians must warn patients…